Harvard School of Public Health
Boston, Massachusetts, 02115, United States
NCT Number: NCT00011440
This study is designed to investigate whether exposure to particulate air pollution increases the allergic response to allergens. Research studies suggest that symptoms in individuals with allergies may be aggravated by exposure to particulate air pollution. We sought to experimental determine this by exposing human volunteers to combustion particles, a component of air pollution, and then challenge them with an allergen such as ragweed or oak tree pollen. Using biological tests we can measure whether the allergen response is magnified by prior particulate exposure.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Boston, Massachusetts, 02115, United States
To study whether particulates enhance the allergic response, we chose the upper airway as a model of allergic inflammation and nasal lavage as a non-invasive method for obtaining samples. The nasal cavity is both an excellent model of allergic inflammation and provides an easily accessible site for study. We measured inflammatory cells and cytokines in the nasal lavage fluid. Our specific hypothesis was that particulate exposure prior to allergen challenge would enhance inflammatory cell recruitment and expression of inflammatory cytokines.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Adult without a history of asthma or respiratory disease.
National Institute of Environmental Health Sciences (NIEHS)
Nih
Markers of Pollutant Altered Allergic Responses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05476484
Allergic Rhinitis, Allergy
Hørsholm, Copenhagen, Denmark
View Trial DetailsNCT02090374
Actinomycetales Infections, Allergic Rhinitis
Paddington, London, United Kingdom
View Trial DetailsNCT02352168
Allergic Rhinitis, Hypersensitivity
Guangzhou, Guangdong, China
View Trial DetailsNCT01522703
Allergic Rhinitis, Allergy
Baltimore, Maryland, United States
View Trial Details